Salesforce: The SaaSpocalypse Created A Rare Buying Opportunity

Double-digit revenue growth and robust free cash flow underpin the view that Salesforce (CRM) is materially undervalued following market overreaction to AI-driven SaaS fears. Geographic and product diversification support resilient revenue; AI is expected to enhance CRM via platform integration, agentic workflows, and expanding Agentic Work Units rather than erode monetization. The note implies mispriced downside risk and potential upside as AI adoption converts into incremental platform monetization for a mature compounder.

Analysis

AI will primarily re-rate the economics of software adjacencies rather than the core CRM licensing model; the second-order winners are integration and infra layers — Mulesoft-like connectors, AppExchange ISVs, and GPU/cloud providers — because incremental AWUs compound API, storage, and inference spend faster than seat growth alone. Expect a lumpy but measurable step-up in per-customer cloud/consumption revenue within 3–12 months as pilot AWUs convert to production, which should drive higher gross margins at the platform level even if headline ARR growth stays steady.

Key near-term catalysts are measurable adoption signals: % of large accounts with >1 production AWU, average inference spend per account, and ARR contribution from platform/consumption vs license. Tail risks include rapid commoditization of model infra (open-source LLMs lowering costs), aggressive outcome-based pricing pilots that compress ASPs, and regulatory constraints on data use that could slow enterprise rollouts — any one can flip market sentiment within a quarter.

The consensus misses how deeply embedded workflow lock-in protects pricing power: switching both data lineage and automated AWUs is operationally expensive, creating asymmetric upside for CRM if it executes. That said, the market has a binary reaction function to AI news; expect volatility around earnings and AI product milestones — base case: structured upside of 25–40% over 12–18 months if adoption metrics print, downside 20–30% if they don’t. Trade sizing should therefore be event-aware and skewed to capture platform optionality while protecting against cadence-driven drawdowns.

Key Decisions for Investors

• Long CRM via LEAPs: Buy CRM Jan 2028 ATM LEAP calls (12–24 month horizon). Target +35–45% upside if platform consumption accelerates; max loss = premium. Scale in on any post-earnings pullback of ~10–15%.
• Pairs trade: Long CRM / Short NOW (equal-dollar, 12 months). Rationale: CRM benefits from broad platform lock-in and AppExchange monetization vs NOW’s narrower workflow exposure. Target relative outperformance of 200–400 bps; risk is macro-driven multiple compression affecting both names.
• Buy-write income: Purchase CRM stock and sell 6–9 month 10–15% OTM calls to harvest premium while retaining directional upside. Expected yield enhancement ~5–8% over the period; downside protected only by premium (not capital protected).
• Put-selling for tactical entry: Sell 3–6 month puts 8–12% OTM to acquire CRM at a cheaper basis if comfortable owning at that level; collect premium as effective yield while waiting for AI adoption proofs. Risk: assignment into a meaningful drawdown if adoption disappoints.